Sign in to view content

Inhibition of Complement C3 in GA with NGM621: Phase 1 Study Results

David A. Eichenbaum, MD, FASRS

Video
Published 2021

Related

First Time Results of VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy
Omer Trivizki, MD, MBA
Updates from the Field
2025
Beyond Complement: A Novel FAS Inhibition Approach for Neuroprotection in GA
Vaidehi S. Dedania, MD
Updates from the Field
2024
Particulate Matter From Syringes Used for Intravitreal Injections
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2020

Category: Pharmacology

See more